Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma and Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07811687
What this trial is testing

Effect of Laparoscopic Hepatectomy Combined With Splenectomy on Hepatic Functional Reserve and Immune Function

Who this might be right for
Liver CirrhosisHCC - Hepatocellular CarcinomaHypersplenism
Northern Jiangsu People's Hospital 30
Not applicableNot Yet RecruitingNCT06069947
What this trial is testing

SALT for Liver Cirrhosis With HCC

Who this might be right for
HCCLiver Cirrhosis
RenJi Hospital 40
Not applicableUnknownNCT06205732
What this trial is testing

A Retrospective Study on the Treatment of Intermediate and Advanced Liver Cancer.

Who this might be right for
Carcinoma, Hepatocellular
Qianfoshan Hospital 100
Not applicableStudy completedNCT05720195
What this trial is testing

ALBI and PALBI Scores and HCC Prognosis

Who this might be right for
Hepatocellular Carcinoma (HCC) Prognosis
Sohag University 645
Not applicableUnknownNCT06325267
What this trial is testing

Clinical Characteristics of Primary Liver Cancer

Who this might be right for
Primary Liver Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 1,000
Testing effectiveness (Phase 2)UnknownNCT03864211
What this trial is testing

Thermal Ablation Followed by Immunotherapy for HCC

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Xiangya Hospital of Central South University 145
Large-scale testing (Phase 3)Ended earlyNCT01821963
What this trial is testing

Telaprevir Plus Standard of Care (SOC) in HCV Associated Hepatocellular Carcinoma (HCC)

Who this might be right for
Infection
M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT03575806
What this trial is testing

Combine TACE and Autologous Tcm Immunotherapy Versus TACE Alone for HCC With MVI After Radical Resection

Who this might be right for
Hepatocellular CarcinomaMalignant Neoplasm
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 52
Very early researchStudy completedNCT02013492
What this trial is testing

Propranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot Be Removed By Surgery

Who this might be right for
Male Breast CancerRecurrent MelanomaStage IV Breast Cancer+5 more
William Carson 1
Not applicableLooking for participantsNCT06487663
What this trial is testing

TACE Combined With Immune Checkpoint Inhibitors for Liver Malignant Tumors

Who this might be right for
Hepatocellular Carcinoma Non-resectableCholangiocarcinoma Non-resectableLiver Metastases+1 more
Tianjin Medical University Cancer Institute and Hospital 40
Not applicableLooking for participantsNCT07623265
What this trial is testing

Improving the Use of Immunotherapy to Treat Liver Cancer

Who this might be right for
Hepatocellular Carcinoma (HCC)
Universitaire Ziekenhuizen KU Leuven 300
Post-approval studies (Phase 4)Study completedNCT00646100
What this trial is testing

Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 164
Not applicableEnded earlyNCT00375011
What this trial is testing

Breath Test to Assess Hepatic Metabolic Reserve and to Predict Hepatic Decompensation in Cirrhotics

Who this might be right for
Cirrhosis
Meridian Bioscience, Inc. 200
Not applicableEnded earlyNCT00469963
What this trial is testing

Internal Radiation Therapy in Treating Patients With Primary Liver Cancer That Cannot Be Removed by Surgery

Who this might be right for
Liver Cancer
Vanderbilt-Ingram Cancer Center 12
Very early researchUnknownNCT03099564
What this trial is testing

Pembrolizumab Plus Y90 Radioembolization in HCC Subjects

Who this might be right for
Hepatocellular Carcinoma
Ashwin Somasundaram 30
Testing effectiveness (Phase 2)UnknownNCT02809534
What this trial is testing

Anlotinib in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 60
Large-scale testing (Phase 3)UnknownNCT01861912
What this trial is testing

Arsenic Trioxide TACE and Intravenous Administration in Unresectable Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Guangdong Provincial People's Hospital 258
Not applicableUnknownNCT05811481
What this trial is testing

Regorafenib Alone or in Combined With Transcatheter Arterial ChEmoembolization in Treatment of Advanced Hepatocellular Carcinoma After First Line Targeted Therapy

Who this might be right for
Hepatocellular CarcinomaTranscatheter Arterial ChEmoembolizationRegorafenib
WenBo Guo 192
Testing effectiveness (Phase 2)Study completedNCT00052364
What this trial is testing

Oxaliplatin in Treating Patients With Liver Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
National Cancer Institute (NCI) 32
Not applicableLooking for participantsNCT05466565
What this trial is testing

Antiviral Therapy for Patients With Liver Cancer After Surgery

Who this might be right for
Hepatocellular Carcinoma
Xiangya Hospital of Central South University 360
Next Page